A systems biology approach for the study of cumulative oncogenes with applications to the MAPK signal transduction

Dhruv K Pant1, Avijit Ghosh

  • 1Drexel University, 3141 Chestnut St, Philadelphia, PA, 19104 United States.

Biophysical Chemistry
|September 28, 2005
PubMed

Insights

This study extends a computational method to identify cancer-driving mutations in the Extracellular signal Regulated Kinase (ERK) pathway. It reveals how combined mutations synergistically promote malignant transformation, with top single mutations also ranking high in pairs.

Area of Science:

  • Cellular signaling pathways
  • Cancer biology
  • Bioinformatics

Background:

  • The Extracellular signal Regulated Kinase (ERK) pathway is crucial for cell cycle regulation, and its dysfunction is implicated in various cancers.
  • Previous work introduced a method to predict oncogenic single point mutations in signaling networks.
  • Understanding cooperative mutations is vital for comprehending cancer development.

Purpose of the Study:

  • To extend a computational method for predicting mutations that cause cellular transformation.
  • To analyze synergistic or cooperative pair mutations in enzyme/protein interactions and expression levels within the MAPK signaling pathway.
  • To quantitatively rank modifier pairs affecting ERK activation and their contribution to malignant transformation.

Main Methods:

  • Extension of a previously developed computational approach for mutation prediction.
  • Application of the method to the MAPK signaling pathway to study pair mutations.
  • Quantitative ranking of mutation pairs influencing ERK activation.
  • Validation of computational findings against experimental literature.
  • Utilizing second-order sensitivity analysis to assess mutation correlations.

Main Results:

  • The study successfully extended a method to analyze pair mutations in signaling pathways.
  • A quantitative ranking of mutation pairs affecting ERK activation was generated.
  • Highest-ranking single point mutations were found to be components of the highest-ranking pair mutations.
  • Results were validated using existing experimental literature on multiple mutations.
  • Sensitivity analysis provided insights into correlated mutation effects.

Conclusions:

  • The extended computational method effectively identifies synergistic mutations driving cancer in signaling pathways.
  • Cooperative mutations within the ERK pathway play a significant role in malignant transformation.
  • The findings highlight the importance of considering combined mutational effects in cancer research.
  • The study provides a quantitative framework for ranking mutation pairs and understanding their impact on pathway activation.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...